3d cell omics – clinical proteomics platform

For your Clinical investigations, they propose to apply 3D culture cell methods to further your knowledge of disease, pathways, targets and drugs effects. rnrn3D Cell Omics offers :rn- Technology that mimics the tumor microenvironmentrn- Study of drug effects on different cell line, rn- Drug following by mass spectrometry imaging,rn- Biomarkers hunting,rn- Large scale proteins identification and relative quantification.rnrn3D Cell Omics will assist you throughout all steps of your project from culture of your cell lines to the data analysis. rnrn- Maintenance of cell linesrn- Access to innovative technologies : creation of mixed spheroid, invasion computation software, 3D organs Bioprinting, exosome isolation and count …rn- Data processing and statistical analysis for identifications and relative quantification of markers.rnrnrnFor more information : http://www.laboratoire-prism.fr/index.php/platforms/3d-cellomics

Interest / Relevance: - Large index of cell lines (30 different cell line from different species).rn- Mixed spheroid creation : association of cancer cells AND immune cells in 3D culture for mimic tissue microenvironnement.rn- Large scale of different test : invasion test, viability test, MS/MS, imaging, fluorescence.rn- 3D organs bioprinting.rn- Exosome isolation and count with Nanosight.rn- Isolated organs, biopsies, tissue sections, isolated cells layer, 2D or 3D cell culture, cell secretomes and body fluids (plasma, CSF) .rn- Combined Multi-Omics analysis (metabolomics, lipidomics and proteomics).rn- Design, execution and analysis of experiments.rn- Get closer to the tumor microenvironment for testing drugs.rnrnUp-to-date software for data analysis, proteins identification, label free quantification and invasion area quantification.rnMembers of 3D Cell Omics platform lead research efforts in proteomics area to apply these cutting-edge methods to answer your question.
Scientist's name: Michel SALZET
Publications:
1). ChemPhysChem. 2018 doi: 10.1002/cphc.201701198rnrn2). MCP. 2018 doi: 10.1074/mcp.RA117.000443rnrn3). Sci Rep. 2016 doi: 10.1038/srep19360rnrn4). MCP. 2015 doi: 10.1074/mcp.M115.052480

Reference:

RT00507

Business Developper
contact
Inserm Transfert
Research Tools
Accessible for: Fee-for-service research, Collaboration, Training / Know-How License
Equipment available: Exosome counter, Nanosight, 3D organoid bioprinter, biobots, Ventana histological robot...
Samples/Models available: null
Rare disease: No
Last update: 12/06/2024

You might also be interested in